FDA
approval
· 2025-12-22
FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
Summary
The FDA approved a supplemental application for MS CONTIN (morphine sulfate) submitted by Rhodes Pharmaceuticals L.P., resulting in an update to the product lab…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MS CONTIN (MORPHINE SULFATE)